These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8490568)

  • 1. Retinoblastoma gene inhibits transactivation of HIV-LTR linked gene expression upon co-transfection in He La cells.
    Prasad MV; Shanmugam G
    Biochem Mol Biol Int; 1993 Jan; 29(1):57-62. PubMed ID: 8490568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High expression of exogenous cDNAs directed by HIV-1 long terminal repeat in human cells constitutively producing HIV-1 tat and adenovirus E1A/E1B.
    Negrini M; Rimessi P; Sabbioni S; Caputo A; Balboni PG; Gualandri R; Manservigi R; Grossi MP; Barbanti-Brodano G
    Biotechniques; 1991 Mar; 10(3):344-53. PubMed ID: 1829615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene activation mediated by protein kinase C in human macrophage and teratocarcinoma cells expressing aminoglycoside phosphotransferase activity.
    Maio JJ; Brown FL
    J Cell Physiol; 1991 Dec; 149(3):548-59. PubMed ID: 1660486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of relative promoter strengths of the HIV-1-LTR and a chimeric RSV-LTR in T lymphocytic cells and peripheral blood mononuclear cells: promoters for anti-HIV-1 gene therapies.
    Mukhtar M; Duan L; Bagasra O; Pomerantz RJ
    Gene Ther; 1996 Aug; 3(8):725-30. PubMed ID: 8854098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of HIV-LTR activity by ras oncogenes.
    Lembo D; Angeretti A; Gaboli M; Cavallo R; Landolfo S
    New Microbiol; 1995 Apr; 18(2):111-6. PubMed ID: 7603337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the human immunodeficiency virus type I long terminal repeat by 1 alpha,25-dihydroxyvitamin D3.
    Nevado J; Tenbaum SP; Castillo AI; Sánchez-Pacheco A; Aranda A
    J Mol Endocrinol; 2007 Jun; 38(6):587-601. PubMed ID: 17556530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of the basal-level activity of HIV-1 long terminal repeat by HIV-1 nucleocapsid protein.
    Zhang JL; Sharma PL; Crumpacker CS
    Virology; 2000 Mar; 268(2):251-63. PubMed ID: 10704334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Epstein-Barr virus DNA polymerase transactivates the human immunodeficiency virus type 1 5' long terminal repeat.
    Lin JC
    Biochem Biophys Res Commun; 1993 Aug; 195(1):242-9. PubMed ID: 8395825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An autocrine loop of HIV type-1 Tat protein responsible for the improved survival/proliferation capacity of permanently Tat-transfected cells and required for optimal HIV-1 LTR transactivating activity.
    Zauli G; La Placa M; Vignoli M; Re MC; Gibellini D; Furlini G; Milani D; Marchisio M; Mazzoni M; Capitani S
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Nov; 10(3):306-16. PubMed ID: 7552492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of NF-kappaB and HIV-1 LTR activity in mouse L cells by ultraviolet radiation: LTR trans-activation in a nonirradiated genome in heterokaryons.
    Miller SC; Taylor A; Watanabe K; Mok K; Torti FM
    Exp Cell Res; 1997 Jan; 230(1):9-21. PubMed ID: 9013701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TAT-mediated transcellular activation of HIV-1 long terminal repeat directed gene expression by HIV-1-infected peripheral blood mononuclear cells.
    Thomas CA; Dobkin J; Weinberger OK
    J Immunol; 1994 Oct; 153(8):3831-9. PubMed ID: 7930599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of Tat-associated kinase-independent transcriptional elongation from the human immunodeficiency virus type-1 long terminal repeat by a cellular enhancer.
    West MJ; Karn J
    EMBO J; 1999 Mar; 18(5):1378-86. PubMed ID: 10064603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of HIV-1 Tat-mediated transactivation by quinacrine and chloroquine.
    Jiang MC; Lin JK; Chen SS
    Biochem Biophys Res Commun; 1996 Sep; 226(1):1-7. PubMed ID: 8806583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ribozyme targeting of HIV-1 LTR.
    Ventura M; Wang P; Franck N; Saragosti S
    Biochem Biophys Res Commun; 1994 Sep; 203(2):889-98. PubMed ID: 8093072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of human cytomegalovirus target sequences in the human immunodeficiency virus long terminal repeat. Potential role of IE2-86 binding to sequences between -120 and -20 in promoter transactivation.
    Yurochko AD; Huong SM; Huang ES
    J Hum Virol; 1999; 2(2):81-90. PubMed ID: 10225210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transactivation of human immunodeficiency virus by herpesviruses.
    Rando RF; Pellett PE; Luciw PA; Bohan CA; Srinivasan A
    Oncogene; 1987 Mar; 1(1):13-8. PubMed ID: 2830574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of gamma rays, ultraviolet radiation, sunlight, microwaves and electromagnetic fields on gene expression mediated by human immunodeficiency virus promoter.
    Libertin CR; Panozzo J; Groh KR; Chang-Liu CM; Schreck S; Woloschak GE
    Radiat Res; 1994 Oct; 140(1):91-6. PubMed ID: 7938460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone-mediated transfer and expression of the HIV-1 tat gene in Jurkat cells.
    Demirhan I; Hasselmayer O; Chandra A; Ehemann M; Chandra P
    J Hum Virol; 1998; 1(7):430-40. PubMed ID: 10195264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 regulatory protein tat induces RNA binding proteins in central nervous system cells that associate with the viral trans-acting-response regulatory motif.
    Kundu M; Ansari SA; Chepenik LG; Pomerantz RJ; Khalili K; Rappaport J; Amini S
    J Hum Virol; 1999; 2(2):72-80. PubMed ID: 10225209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The HLA class II transcriptional activator blocks the function of HIV-1 Tat and inhibits viral replication.
    Accolla RS; Mazza S; De Lerma Barbaro A; De Maria A; Tosi G
    Eur J Immunol; 2002 Oct; 32(10):2783-91. PubMed ID: 12355430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.